metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-58 PILOT STUDY OF HEPATITIS E VIRUS SEROPREVALENCE IN HEPATITIS B AND DELTA CA...
Journal Information
Vol. 29. Issue S3.
Abstracts of the 2024 Annual Meeting of the ALEH
(December 2024)
Share
Share
Download PDF
More article options
Vol. 29. Issue S3.
Abstracts of the 2024 Annual Meeting of the ALEH
(December 2024)
Full text access
P-58 PILOT STUDY OF HEPATITIS E VIRUS SEROPREVALENCE IN HEPATITIS B AND DELTA CARRIERS IN THE WESTERN AMAZON
Visits
39
Caio Lopes Borges Andrade1, Luiz Felipe Monteiro Darzé1, Maurício de Souza Campos2, Sidelcina Rugieri Pacheco3, Ezequiel Ridruejo4, Juan Miguel Villalobos Salcedo5, Katia Ingred da Silva Maia5, Tárcio Peixoto Roca5, Deusilene Souza Vieira Dallacqua5, Jucara Magalhaes Simoes1, Robert Eduard Schaer1, Roberto Jose Meyer Nascimento1, Raymundo Paraná Ferreira Filho1, Songeli Menezes Freire1, Maria Izabel Schinoni6
1 Laboratório de Imunologia e Biologia Molecular, Universidade Federal da Bahia, Salvador, Brasil, Salvador, Brasil
2 IDOMED - Instituto de educação médica - Faculdade Estácio, Alagoinhas, Brasil, Alagoinhas, Brasil
3 Hospital Universitário Professor Edgard Santos, Salvador, Brasil, Salvador, Brasil
4 Sección Hepatología, Departamento de Medicina. Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno “CEMIC”. Ciudad Autónoma de Buenos Aires, Argentina., Buenos Aires, Argentina
5 Centro de Medicina Tropical de Rondônia - CEMETRON, Porto Velho, Brasil, Porto Velho, Brasil
6 Laboratório de Imunologia e Biologia Molecular, Universidade Federal da Bahia, Salvador, Brasil; Hospital Universitário Professor Edgard Santos, Salvador, Brasil., Salvador, Brasil
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 29. Issue S3

Abstracts of the 2024 Annual Meeting of the ALEH

More info
Conflict of interest

No

Introduction and Objectives

Hepatitis E virus (HEV) is a zoonotic virus transmitted via the fecal-oral route with a generally favorable prognosis. However, higher risks exist for pregnant or immunocompromised patients. Infection occurs through contaminated food, water, or direct contact with infected blood. Its asymptomatic nature and favorable prognosis likely contribute to underreporting in Brazil, especially in peri-urban and rural areas with limited healthcare access. Objective: To evaluate the seroprevalence of HEV in patients with mono-infection of Hepatitis B and co-infection with Delta virus in Rondônia.

Patients / Materials and Methods

An exploratory cross-sectional study using the Dia.Pro HEV Ab total ELISA kit for serological evaluation of 177 samples from the serum bank of the Molecular Virology Laboratory at Fiocruz-RO of patients with viral hepatitis from the Tropical Medicine Center (CEMETRON) in Rondônia. The samples were stratified into 74 VHD co-infected and 103 HBV mono-infected groups. The diagnosis of the Delta virus was performed using molecular biology on samples collected between 2018 and 2022. The results were analyzed using T-test and chi-square test.

Results and Discussion

The total sample consisted of 177 participants, including 95 men, 54 women, and 28 without information. The average age of participants was 41 years (M = 41), with the Delta group averaging 40 years and the HBV mono-infected group averaging 42 years. Of the 74 VHB-VHD sera, 9 (12.16%) were HEV IgG positive, 58 (78.40%) were non-reactive, and 7 (9.45%) were indeterminate. Among the 103 HBV sera, 9 (8.73%) were HEV IgG positive, 86 (83.50%) were non-reactive, and 8 (7.76%) were indeterminate.

Conclusions

The findings of HEV in HBV and VHD patients in Rondônia showed results similar to those found in studies with other populations. This is the first study on HEV in HBV and VHD patients.

Full text is only aviable in PDF
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos